School of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul, 02841, Republic of Korea; Department of Integrated Biomedical and Life Science, Korea University, Seoul, 02841, Republic of Korea.
School of Biosystem and Biomedical Science, College of Health Science, Korea University, Seoul, 02841, Republic of Korea; Department of Integrated Biomedical and Life Science, Korea University, Seoul, 02841, Republic of Korea; Transdisciplinary Major in Learning Health Systems, Department of Healthcare Sciences, Graduate School, Korea University, Seoul, 02841, Republic of Korea; BK21FOUR R&E Center for Learning Health Systems, Korea University, Seoul, 02841, Republic of Korea.
Neurosci Biobehav Rev. 2021 Sep;128:244-257. doi: 10.1016/j.neubiorev.2021.06.028. Epub 2021 Jun 21.
Autism spectrum disorder (ASD) is a neurodevelopmental disorder with a strong genetic component. Recently developed genomic technologies, including microarray and next-generation sequencing (NGS), have enabled researchers to genetic analyses aimed at identifying genetic variations associated with ASD and to elucidate the genetic architecture of the disorder. Large-scale microarray, exome sequencing analyses, and robust statistical methods have resulted in successful gene discovery and identification of high-confidence ASD genes from among de novo and inherited variants. Efforts have been made to understand the genetic architecture of ASD using whole-genome sequencing and genome-wide association studies aimed at identifying noncoding mutations and common variants associated with ASD. In addition, the development of systems biology approaches has resulted in the integration of genetic findings with functional genomic datasets, thereby providing a unique insight into the functional convergence of ASD risk genes and their neurobiology. In this review, we summarize the latest findings of ASD genetic studies involving large cohorts and discuss their implications in ASD neurobiology and in clinical practice.
自闭症谱系障碍(ASD)是一种具有强烈遗传成分的神经发育障碍。最近开发的基因组技术,包括微阵列和下一代测序(NGS),使研究人员能够进行遗传分析,旨在确定与 ASD 相关的遗传变异,并阐明该疾病的遗传结构。大规模的微阵列、外显子组测序分析和强大的统计方法已经成功地发现了基因,并从新生和遗传变异中确定了高可信度的 ASD 基因。人们一直在努力使用全基因组测序和全基因组关联研究来理解 ASD 的遗传结构,旨在识别与 ASD 相关的非编码突变和常见变异。此外,系统生物学方法的发展导致了遗传发现与功能基因组数据集的整合,从而为 ASD 风险基因及其神经生物学的功能趋同提供了独特的见解。在这篇综述中,我们总结了涉及大样本的 ASD 遗传研究的最新发现,并讨论了它们对 ASD 神经生物学和临床实践的意义。